Life Science industry insights from
Aon’s 2019 Global Risk Management Survey

The Life Science industry is an extremely dynamic, R&D-focused, heavily regulated industry that is confronted with more risks than ever before. Considering this backdrop, it is troubling that many organizations participating in the 2019 Global Risk Management Survey stated that they may be less prepared to manage or mitigate their most critical risks.

Aon’s 2019 Global Risk Management Survey, the seventh of its kind since 2007, is designed to offer organizations the insights necessary to enable better management of risk related volatility and compete in an increasingly complex business environment. The survey gathered input from 60+ Life Science industry respondents across geographies, covering biotechnology, pharmaceutical, medical devices and other industry sub-sectors.

This Life Science industry specific report highlights key insights from the survey findings and provides an interpretation, validation and viewpoint from Aon’s industry experts. It is essential reading for any entity as they evolve their risk register and refine their risk management strategy.

If you have any questions or comments about the Life Science insights, or wish to discuss the results, please contact your Aon account executive and Aon’s Life Science Practice Leaders or visit

Contact our Practice Leaders:

James Walters
Managing Director, US Life Science & Chemical Group

Lars Sørensen
Director, EMEA Life Science & Pharma

Anne-Christine Fischer
Global Life Science Practice Leader